PE20010068A1 - Compuestos derivados de piperidina como inhibidores de renina - Google Patents

Compuestos derivados de piperidina como inhibidores de renina

Info

Publication number
PE20010068A1
PE20010068A1 PE2000000377A PE0003772000A PE20010068A1 PE 20010068 A1 PE20010068 A1 PE 20010068A1 PE 2000000377 A PE2000000377 A PE 2000000377A PE 0003772000 A PE0003772000 A PE 0003772000A PE 20010068 A1 PE20010068 A1 PE 20010068A1
Authority
PE
Peru
Prior art keywords
piperidine
phenyl
compounds
iloximethyl
propoxi
Prior art date
Application number
PE2000000377A
Other languages
English (en)
Inventor
Daniel Bur
Hans-Peter Marki
Wolfgang Wostl
Volker Breu
Eric Vieira
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20010068A1 publication Critical patent/PE20010068A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIPERIDINA DE FORMULA I, DONDE:M R1 ES -(CH2)k-N(R3,R4), -(CH2)k-O-R3, -(CH2)m-R5, -(CH2)l-R6; k ES 2-4; m ES 1-2; l ES 1-3; R2 ES CICLOALQUILALQUILO, 1,1,1-TRIFLUOROETILO, FENILO, BENCILO OPCIONALMENTE SUSTITUIDO CON 1-3 HALOGENO, CIANO, ALCOXILO C1-C3, NITRO; R3 ES H, ALQUILO C1-C3; R4 ES H, ALQUILO C1-C3, ALQUILSULFONILO C1-C3, AMINOSULFONILO, ALQUILAMINOSULFONILO C1-C3, ALQUILAMINOCARBONILO C1-C3, ENTRE OTROS; R5 ES ALCOXICARBONILO C1-C3, AMINOCARBONILO, ALQUILAMINOCARBONILO C1-C3, DIALQUILAMINOCARBONILO C1-C3, CIANO; R6 ES IMIDAZOLILO, TRIAZOLILO; CON LA CONDICION QUE SI EL IMIDAZOLILO O TRIAZOLILO ESTA UNIDO VIA UN ENLACE C-N, l ES 2-3. SON COMPUESTOS PREFERIDOS (3R,4R)-N-[2-[7-[4-[4-[3-(2-METOXI-BENCILOXI)-PROPOXI]-FENIL]-PIPERIDIN-3-ILOXIMETIL]-3,4-DIHIDRO-2H-QUINOLIN-1-IL]-ETIL]-ACETAMIDA; (3R,4R)-3-[7-[4-[4-[3-(2-METOXI-BENCILOXI)-PROPOXI]-FENIL]-PIPERIDIN-3-ILOXIMETIL]-3,4-DIHIDRO-2H-QUINOLIN-1-IL]-PROPAN-1-OL, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS DERIVADOS DE PIPERIDINA SON INHIBIDORES DE LA ENZIMA RENINA POR LO QUE PUEDEN SER UTILES EN EL TRAMIENTO DE ENFERMEDADES COMO RESTENOSIS, GLAUCOMA, INFARTO CARDIACO, HIPERTENSION, INSUFICIENCIA RENAL
PE2000000377A 1999-04-27 2000-04-24 Compuestos derivados de piperidina como inhibidores de renina PE20010068A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108200 1999-04-27

Publications (1)

Publication Number Publication Date
PE20010068A1 true PE20010068A1 (es) 2001-01-29

Family

ID=8238051

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000377A PE20010068A1 (es) 1999-04-27 2000-04-24 Compuestos derivados de piperidina como inhibidores de renina

Country Status (22)

Country Link
US (1) US6197959B1 (es)
EP (1) EP1180103B1 (es)
JP (1) JP3602449B2 (es)
KR (1) KR100476916B1 (es)
CN (1) CN1323079C (es)
AR (1) AR018717A1 (es)
AT (1) ATE363478T1 (es)
AU (1) AU761392B2 (es)
BR (1) BR0010076A (es)
CA (1) CA2370244C (es)
CO (1) CO5170512A1 (es)
CZ (1) CZ20013737A3 (es)
DE (1) DE60035039T2 (es)
ES (1) ES2286021T3 (es)
HU (1) HUP0200881A3 (es)
MX (1) MXPA01010855A (es)
PE (1) PE20010068A1 (es)
PL (1) PL362903A1 (es)
SK (1) SK15172001A3 (es)
TR (1) TR200103067T2 (es)
WO (1) WO2000064887A1 (es)
ZA (1) ZA200108739B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
TW200513461A (en) * 2003-10-01 2005-04-16 Speedel Experimenta Ag Organische verbindungen
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
CA2546264A1 (en) * 2003-11-26 2005-06-09 Novartis Ag 4-phenylpiperidine derivatives as renin inhibitors
AR053406A1 (es) * 2004-07-09 2007-05-09 Speedel Experimenta Ag Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas
ATE551052T1 (de) 2004-10-08 2012-04-15 Novartis Ag Verwendung von reninhemmern zur prävention oder behandlung von diastolischer dysfunktion oder diastolischer herzinsuffizienz
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
EP1707202A1 (de) * 2005-03-31 2006-10-04 Speedel Experimenta AG Organische Verbindungen
EP1897879A3 (en) * 2005-03-31 2008-06-11 Speedel Experimenta AG 2,4,5-substituted piperidines as renin inhibitors
ES2352564T3 (es) * 2005-03-31 2011-02-21 Novartis Ag Piperidinas sustituidas.
AR053836A1 (es) * 2005-03-31 2007-05-23 Speedel Experimenta Ag Piperdinas 3,4,5-sustituidas
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
EP1885718B1 (en) * 2005-05-11 2017-03-15 Life Technologies Corporation Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use
WO2006129237A2 (en) 2005-05-27 2006-12-07 Actelion Pharmaceuticals Ltd Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
PL2420491T3 (pl) * 2005-12-30 2013-12-31 Novartis Ag 3,5-Podstawione piperydyny jako inhibitory reniny
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds
AU2008267287B2 (en) 2007-06-25 2012-02-16 Novartis Ag N5-(2-ethoxyethyl)-N3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
AU2008320806A1 (en) * 2007-11-02 2009-05-07 Novartis Ag 4,4-disubstituted piperidines as renin inhibitors
MX2011011735A (es) * 2009-05-04 2011-11-29 Plexxikon Inc Compuestos y metodos para la inhibicion de renina, e indicaciones para ello.
WO2013045505A1 (en) 2011-09-28 2013-04-04 Novartis Ag Biomarkers for raas combination therapy
EP2810644A1 (en) 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256326C (zh) * 1995-09-07 2006-05-17 弗·哈夫曼-拉罗切有限公司 治疗心脏和肾功能不全的新型4－(氧烷氧基苯基)－3－氧哌啶化合物

Also Published As

Publication number Publication date
JP3602449B2 (ja) 2004-12-15
AU4750100A (en) 2000-11-10
CO5170512A1 (es) 2002-06-27
CA2370244C (en) 2007-03-27
ES2286021T3 (es) 2007-12-01
ZA200108739B (en) 2003-01-23
EP1180103B1 (en) 2007-05-30
DE60035039T2 (de) 2008-02-07
KR20020005017A (ko) 2002-01-16
TR200103067T2 (tr) 2002-05-21
CA2370244A1 (en) 2000-11-02
CZ20013737A3 (cs) 2002-04-17
JP2002543072A (ja) 2002-12-17
MXPA01010855A (es) 2002-05-06
DE60035039D1 (de) 2007-07-12
BR0010076A (pt) 2002-01-15
WO2000064887A1 (en) 2000-11-02
HUP0200881A2 (en) 2002-08-28
SK15172001A3 (sk) 2002-06-04
HUP0200881A3 (en) 2003-05-28
ATE363478T1 (de) 2007-06-15
AU761392B2 (en) 2003-06-05
PL362903A1 (en) 2004-11-02
CN1349524A (zh) 2002-05-15
US6197959B1 (en) 2001-03-06
EP1180103A1 (en) 2002-02-20
AR018717A1 (es) 2001-11-28
KR100476916B1 (ko) 2005-03-17
CN1323079C (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
PE20010068A1 (es) Compuestos derivados de piperidina como inhibidores de renina
PE20010069A1 (es) Compuestos derivados de piperidina como inhibidores de renina
PE20060627A1 (es) Derivados de pirazol condensado como agonistas de los receptores cannabinoides cb1 y/o cb2
UY25230A1 (es) Derivados de la d-prolina
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
PE20040290A1 (es) Derivados de piperidinas- benzodiazepinas como antagonistas del cgrp
PE20051173A1 (es) Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3
PE20040600A1 (es) Derivados de triazol como antagonistas del receptor de taquicinina
AR044163A1 (es) Derivados de pirazol sustituidos, composiciones farmaceuticas que los contienen y compuestos relacionados como antagonistas del receptor de bradiquinina b1
PE20030547A1 (es) Derivados de imidazol para el tratamiento de la obesidad
ATE103604T1 (de) Substituierte 5-((tetrazolyl)alkenyl>-imidazole.
PE20050132A1 (es) Piperazinas heterociclicas sustituidas
PE20060625A1 (es) Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina
PE20060653A1 (es) Derivados triciclicos condensados como moduladores del receptor 5-ht1
AU687192B2 (en) Benzocycloalkylazolethione derivatives
PE20081850A1 (es) Derivados ciclizados como inhibidores de la eg-5
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
PE20061155A1 (es) Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
PE20070355A1 (es) Antagonistas de cgrp seleccionados y procedimientos para su preparacion
PE20040762A1 (es) Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
PE20000329A1 (es) Derivados de indol y composiciones farmaceuticas que los contienen
PE83999A1 (es) Azetidinas
PE20040698A1 (es) Derivados de isoindolina

Legal Events

Date Code Title Description
FC Refusal